Mechanistic Insights into Antibiofilm Activity Against Meropenem-Resistant Acinetobacter baumannii
journal of medical and oral biosciences · 01.06.2026 · 3 (2) · 55-68
DOI: 10.58564/jmob.119 ↗Kurz gefasst
Fachartikel in der Zeitschrift journal of medical and oral biosciences, online erschienen am 30.05.2026. Verfasst von Nada Khalil Ibrahim und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Acinetobacter baumannii is considered the third most common cause of catheter-associated urinary tract infections (UTIs). Its ability to form biofilms and produce urease contributes to catheter blockage, enhancing its virulence and reducing the effectiveness of antibiotics. UTIs caused by A. baumannii are increasingly concerning, and meropenem remains a last-resort treatment for infections caused by this pathogen. However, the emergence of meropenem-resistant (MER-R) A. baumannii has severely compromised its clinical effectiveness. This study aimed to investigate the antibiofilm activity and underlying mechanisms associated with MER-R A. baumannii. Urine samples were collected from 102 patients referred to Baghdad Medical City and immediately placed in sterile tubes before initial culture on MacConkey agar. Identification and confirmation of bacterial isolates were performed using the Vitek® 2 Compact system with a Gram-negative (GN) identification card, which includes 48 biochemical tests. Antibiotic susceptibility testing and biofilm activity assays of A. baumannii were also conducted. The results confirmed the isolation of A. baumannii. Antibiotic susceptibility testing revealed that a sub-minimum inhibitory concentration (sub-MIC) of 62 µg/mL meropenem exhibited a significant biofilm-inhibitory effect against multidrug-resistant wild-type A. baumannii strains. Strong biofilm-producing isolates were incubated with 1 mL of sub-MIC colistin for 24 and 48 hours at 37 °C. Meropenem was further evaluated for its ability to inhibit biofilm formation by A. baumannii. Conclusion: This study highlighted the mechanisms underlying antibiofilm activity against meropenem-resistant A. baumannii. Targeting biofilm formation and associated virulence factors can significantly reduce bacterial colonization and catheter obstruction, offering a promising strategy to enhance treatment efficacy and improve patient outcomes. These findings provide valuable insights for developing alternative therapeutic approaches against multidrug-resistant A. baumannii infections.
Zitieren
APA
Ibrahim, N. K., Jameel, S. K., & Ahmed, M. E. (2026). Mechanistic Insights into Antibiofilm Activity Against Meropenem-Resistant Acinetobacter baumannii. journal of medical and oral biosciences, 3(2), 55-68. https://doi.org/10.58564/jmob.119
Vancouver
Ibrahim NK, Jameel SK, Ahmed ME. Mechanistic Insights into Antibiofilm Activity Against Meropenem-Resistant Acinetobacter baumannii. journal of medical and oral biosciences. 2026;3(2):55-68. doi:10.58564/jmob.119
BibTeX
@article{Ibrahim2026,
author = {Ibrahim, Nada Khalil and Jameel, Sanaa Khudhur and Ahmed, Mais Emad},
title = {Mechanistic Insights into Antibiofilm Activity Against Meropenem-Resistant Acinetobacter baumannii},
journal = {journal of medical and oral biosciences},
year = {2026},
volume = {3},
number = {2},
pages = {55--68},
doi = {10.58564/jmob.119}
}
EUVIMED